UY26537A1 - Dispositivo osmótico que contiene ranitidina y un agente procinético - Google Patents
Dispositivo osmótico que contiene ranitidina y un agente procinéticoInfo
- Publication number
- UY26537A1 UY26537A1 UY26537A UY26537A UY26537A1 UY 26537 A1 UY26537 A1 UY 26537A1 UY 26537 A UY26537 A UY 26537A UY 26537 A UY26537 A UY 26537A UY 26537 A1 UY26537 A1 UY 26537A1
- Authority
- UY
- Uruguay
- Prior art keywords
- osmotic device
- agent
- external coating
- ranitidine
- coated
- Prior art date
Links
- 230000003204 osmotic effect Effects 0.000 title abstract 4
- VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title abstract 3
- 229960000620 ranitidine Drugs 0.000 title abstract 3
- 239000002325 prokinetic agent Substances 0.000 abstract 4
- 239000011248 coating agent Substances 0.000 abstract 3
- 238000000576 coating method Methods 0.000 abstract 3
- 238000013270 controlled release Methods 0.000 abstract 2
- 239000000945 filler Substances 0.000 abstract 2
- 239000007921 spray Substances 0.000 abstract 2
- 230000006835 compression Effects 0.000 abstract 1
- 238000007906 compression Methods 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4468—Non condensed piperidines, e.g. piperocaine having a nitrogen directly attached in position 4, e.g. clebopride, fentanyl
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US17584400P | 2000-01-13 | 2000-01-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UY26537A1 true UY26537A1 (es) | 2001-07-31 |
Family
ID=22641875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UY26537A UY26537A1 (es) | 2000-01-13 | 2001-01-12 | Dispositivo osmótico que contiene ranitidina y un agente procinético |
Country Status (4)
| Country | Link |
|---|---|
| AR (1) | AR026837A1 (fr) |
| AU (1) | AU2001227744A1 (fr) |
| UY (1) | UY26537A1 (fr) |
| WO (1) | WO2001051039A1 (fr) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI1103093A2 (pt) * | 2011-06-03 | 2013-07-02 | Eurofarma Laboratarios Ltda | composiÇço farmacÊutica oral e uso da composiÇço farmacÊutica oral |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2203963T3 (es) * | 1997-05-30 | 2004-04-16 | Osmotica Corp. | Dispositivo osmotico multicapa. |
-
2001
- 2001-01-09 WO PCT/US2001/000610 patent/WO2001051039A1/fr not_active Ceased
- 2001-01-09 AU AU2001227744A patent/AU2001227744A1/en not_active Abandoned
- 2001-01-12 UY UY26537A patent/UY26537A1/es not_active Application Discontinuation
- 2001-01-12 AR ARP010100142A patent/AR026837A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR026837A1 (es) | 2003-02-26 |
| AU2001227744A1 (en) | 2001-07-24 |
| WO2001051039A1 (fr) | 2001-07-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY26534A1 (es) | Dispositivo osmótico que contiene alprazolam y un agente antipsicótico | |
| UY26525A1 (es) | Dispositivo osmótico que contiene pseudoefedrina y un antagonista h1 | |
| BR0013826A (pt) | Formas orais de apresentação | |
| BRPI0507473A (pt) | cápsula de gelatina mole, uso de pelo menos um ácido graxo polinsaturado Èmega-3, processo para a manufatura de uma cápsula de gelatina mole, uso de gelatina extraìda por um processo de extração, e, método de tratamento ou de profilaxia de uma condição | |
| BRPI0519212A2 (pt) | composiÇÕes farmacÊuticas de desintegraÇço oral contendo agentes de manifestaÇço sensorial | |
| CA2396156A1 (fr) | Dispositif osmotique contenant de la venlafaxine et un agent antipsychotique | |
| CO5150154A1 (es) | Composicion de sustrato y metodo para usarlo para el secuestro de irritantes de la piel | |
| CR6656A (es) | Forma de dosificacion de farmacos accionada por un hidrogel | |
| BRPI0409715A (pt) | pelìculas comestìveis de dissolução rápida contendo um edulcorante | |
| BRPI0309142B8 (pt) | suspensão de microcápsulas em uma fase líquida aquosa, que permite a liberação modificada de pelo menos um princípio ativo com exclusão da amoxicilina e que é destinada a ser administrada por via oral | |
| UY27386A1 (es) | Dispositivo de liberación de droga que contiene oseltamivir y un antagonista h1 | |
| ES2130217T3 (es) | Uso de tiloxapol como dispersante y estabilizante de nanoparticulas. | |
| BR0209221A (pt) | Pastilha medicamentosa de açúcar cozido para chupar e processo de fabricação da mesma | |
| ES2149781T3 (es) | Composiciones de risedronato de liberacion retardada. | |
| BR0214184A (pt) | Composições que contêm óleos que possuem gravidade especìfica mais alta que a gravidade especìfica da água | |
| BR0312268A (pt) | Dispositivos transdermais para liberação de droga que têm microprotrusões revestidas | |
| CL2018001420A1 (es) | Tratamiento de trastornos cognitivos con (r)-7-cloro-n-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma. (divisional solicitud 201701853) | |
| GT199900203A (es) | Composiciones de celecoxib. | |
| DE60212847D1 (de) | Topisch anwendbare arzneimittelformulierung | |
| ES2044825T3 (es) | Formulaciones de matriz de liberacion retardada. | |
| AR071183A1 (es) | Composicion oral que comprende un componente activo y un componente formador de pelicula adhesiva, metodo | |
| BRPI0412697A (pt) | composições farmacêuticas que apresentam um revestimento expansìvel | |
| BRPI0212298B8 (pt) | composição farmacêutica compreendendo gabapentina ou um análogo da mesma e (alfa)-aminoamida e seu uso analgésico | |
| BRPI0417585A (pt) | composição pregabalina | |
| BR0114272A (pt) | Formulação farmacêutica de liberação prolongada independente da força iÈnica |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 109 | Application deemed to be withdrawn |
Effective date: 20121115 |